Guangzhou-based biopharmaceutical company developing innovative small-molecule drugs for cancers and autoimmune diseases
Guangzhou-based biopharmaceutical company developing innovative small-molecule drugs for cancers and autoimmune diseases. Its pipeline includes targeted therapies such as BTK, Bcl-2, and Bcl-xL inhibitors, with clinical development in China, the United States, and Europe.